The VC-01 product candidate is currently being evaluated in patients with type 1 diabetes who have minimal to no insulin-producing beta cell function. The location and enrollment start date of the first Canadian clinical trial site have not yet been disclosed.
http://ift.tt/1wxdwcg
http://ift.tt/1wxdwcg
No comments:
Post a Comment